187. 歌舞伎症候群
［臨床試験数：2，薬物数：7（DrugBank：2），標的遺伝子数：3，標的パスウェイ数：15］
Searched query = "Kabuki syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2012-000432-26-NL (EUCTR) | 26/09/2012 | 27/03/2012 | Prospective study on the metabolic and linear growth effects of growh hormone treatment in children with Kabuki Syndrome | Prospective study on the metabolic and linear growth effects of growh hormone treatment in children with Kabuki Syndrome - Metabolic effects of Growth Hormone | Kabuki Syndrome (KS, OMIM 147920) with a mutation in MLL2 gene. ;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03] | Trade Name: Genotropin Product Name: Genotropin INN or Proposed INN: SOMATROPIN Other descriptive name: recombinant DNA-derived human growth hormone | Maastricht University Medical Centre | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Netherlands |